Company / Free Cash Flow
Innoviva, Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$195.8M
FY2025
5-year range
$140.7M / $363.8M
FY2021-FY2025
Trend
+3.9%
vs FY2024
Sector context
#34 of 194
Health Care
What the data says
Innoviva, Inc.'s free cash flow of $196M is higher than 82% of companies in the Health Care sector (FY2025). Free Cash Flow has fluctuated over the past 10 years, ranging from $61M in FY2018 to $364M in FY2021.
Based on SEC 10-K filings.
$196M in FY2025 with a 5-year CAGR of -9.0%. Top quartile in the Health Care sector.
Improved from $141M to $196M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -14.5%
- 5-Year CAGR
- -9.0%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 194This company $195.8M Sector average $470.8M
▼
-58.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -9.0%, indicating a declining trend.
- In FY2025, free cash flow increased 3.9% year-over-year.
- Ranks #34 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $195.8M | +3.9% |
| FY2024 | $188.4M | +34.0% |
| FY2023 | $140.7M | -55.1% |
| FY2022 | $313.1M | -13.9% |
| FY2021 | $363.8M | +16.2% |
| FY2020 | $313.1M | +120.9% |
| FY2019 | $141.7M | +133.5% |
| FY2018 | $60.7M | -57.2% |
| FY2017 | $141.7M | +133.5% |
| FY2016 | $60.7M | +499.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026